Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
about
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dual mTorc Inhibition in advan ...... rous Type, and Carcinosarcoma)
@en
type
label
Dual mTorc Inhibition in advan ...... rous Type, and Carcinosarcoma)
@en
prefLabel
Dual mTorc Inhibition in advan ...... rous Type, and Carcinosarcoma)
@en
P6153
P1476
An International Multi-centre ...... rous Type, and Carcinosarcoma)
@en
P1813
DICE
@en
P3098
NCT03648489
P4844
P580
2018-09-21T00:00:00Z
P582
2022-03-01T00:00:00Z